POLISCOPE
Back to feed
NewsPasadena NowJuly 2, 2026United States

Local Clinical Trial Helps College Athlete Return to Baseball

A 24-year-old college athlete diagnosed with a chronic kidney disease was able to return to his sport after participating in a clinical trial at Kaiser Permanente Southern California. The trial provided a treatment option for IgA nephropathy after standard treatments were unsuccessful.

healthcareclinical trialskidney diseasesports medicine
Read the full story at Pasadena Now

Why It Matters

This report highlights the availability of experimental medical treatments for chronic kidney conditions at a local healthcare facility, which may serve as a resource for patients who have exhausted standard care options.

Key Facts

  • Chance Shipley, a 24-year-old college athlete, was diagnosed with IgA nephropathy, a chronic kidney disease.
  • The patient had previously exhausted all available standard treatments for his condition.
  • The patient was forced to stop playing baseball during his freshman year of college due to declining health.
  • The patient enrolled in a clinical trial conducted at Kaiser Permanente Southern California in Pasadena.
  • Following the clinical trial treatment, the patient returned to play baseball for his senior season.

Who's Mentioned

organizationKaiser Permanente Southern California“A Pasadena-based healthcare organization that conducted the clinical trial.”personChance Shipley“A 24-year-old college athlete who participated in a clinical trial.”otherIgA nephropathy“A chronic kidney disease diagnosed in the patient.”